Abbreviations

David B Matchar; Douglas C McCrory; Lori A Orlando; Manesh R Patel; Uptal D Patel; Meenal B Patwardhan; Benjamin Powers; Gregory P Samsa; Rebecca N Gray

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Matchar DB, McCrory DC, Orlando LA, et al. Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Nov. (Comparative Effectiveness Reviews, No. 10.)

See the updated review, "Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), and Direct Renin Inhibitors for Treating Essential Hypertension: An Update"

This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension

Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension [Internet].

Show details

Contents

< Prev Next >

Abbreviations

ACE: Angiotensin-converting enzyme
ACEI(s): Angiotensin-converting enzyme inhibitor(s)
AHRQ: Agency for Healthcare Research and Quality
ARB(s): Angiotensin II receptor blocker(s)/antagonist(s)
AT ₁: Angiotensin specific receptor
CER: Comparative Effectiveness Review
DBP: Diastolic blood pressure
EF: Ejection fraction
EPC: Evidence-based Practice Centers
ESRD: End-stage renal disease
GFR: Glomerular filtration rate
HgbA1c: Glycated hemoglobin
HCTZ: Hydrochlorothiazide
HDL: High-density lipoprotein
LDL: Low-density lipoprotein
LV: Left ventricular
LVEF: Left ventricular ejection fraction
LVH: Left ventricular hypertrophy
LVMI: Left ventricular mass index
MeSH: Medical Subject Headings
MI: Myocardial infarction
RCT: Randomized controlled trial
SBP: Systolic blood pressure
SD: Standard deviation
SF-36: Medical Outcomes Study 36-Item Short Form Health Survey
SRC: Scientific Resource Center
TC: Total cholesterol
TG: Triglyceride
UAE: Urinary albumin excretion
USPSTF: U.S. Preventive Services Task Force

Bookshelf ID: NBK43078

Contents

< Prev Next >

PubReader
Print View
Cite this Page
Matchar DB, McCrory DC, Orlando LA, et al. Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Nov. (Comparative Effectiveness Reviews, No. 10.) Abbreviations.
PDF version of this title (1.3M)

Other titles in these collections

Recent Activity

Clear Turn Off Turn On

Abbreviations - Comparative Effectiveness of Angiotensin-Converting Enzyme Inhib...
Abbreviations - Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension
Expanded phalanges with widened medullary cavities
Expanded phalanges with widened medullary cavities
MedGen

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Bookshelf

Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension [Internet].

Abbreviations

Views

Other titles in these collections

Recent Activity